July 6, 2017 — GE Healthcare and HeartFlow Inc. announced at the annual scientific meeting of the Society of Cardiovascular Computed Tomography (SCCT), that they have entered into a global collaboration agreement with the goal of increasing the clinical availability and adoption of HeartFlow fractional flow reserve computed tomography (FFR-CT), a proprietary technology that helps clinicians diagnose and treat patients with suspected coronary artery disease (CAD).

Bayer has enrolled the first patient in a global Phase IV study assessing the clinical effects of riociguat in patients with pulmonary arterial hypertension (PAH). All enrolled patients were being treated with a Phosphodiesterase-5 inhibitors (PDE-5 inhibitors), either as monotherapy or in combination with an endothelin receptor antagonist (ERA), and who did not reach their therapeutic goal. The study, which is a part of the collaboration between Bayer and Merck, is seeking to enroll patients at 26 sites in the United States with a total of 100 study sites worldwide.

Michigan Medicine recently became the first healthcare institution in the United States to install the Artis pheno, the new robotic C-arm angiography system from Siemens Healthineers. The system is designed to broaden clinical capabilities and expand patient access while combating patient infection.

July 5, 2017 — BioStable Science & Engineering Inc. announced the first commercial uses of the HAART 300 Aortic Annuloplasty Device in the U.S. by doctors at the West Virginia University (WVU) Heart and Vascular Institute in Morgantown, W. Va. Lawrence Wei, M.D., Vinay Badhwar, M.D., and J. Scott Rankin, M.D., of the WVU Heart and Vascular Institute were the collaborating surgeons for the procedures. The WVU Heart and Vascular Institute is the first of a select group of leading U.S.

With worldwide cardiovascular deaths at an all-time high, European scientists have developed a new handheld scanner that can read the heart's vital signs like a supermarket barcode reader can scan items at the checkout. This would allow a general practitioner (GP) to diagnose even preclinical patients for the early onset of a disease.

Medtronic recently announced that its Reactive ATP therapy slows the progression of atrial fibrillation (AF) in patients with implanted cardiac devices. A robust, real-world analysis of nearly 8,800 patients was presented as a late breaking clinical trial at EHRA EUROPACE-CARDIOSTIM 2017, June 18-21 in Vienna, Austria.

When diagnosing strokes and heart diseases or looking at tumors, perfusion magnetic resonance imaging (MRI) offers a gentler way to capture the blood flow circulation in the organs. However, the method is far from being implemented to its full potential at many clinics. The Fraunhofer Institute for Medical Image Computing MEVIS in Bremen, Germany organized a workshop entitled “Measurement of Perfusion and Capillary Exchange” from June 21-23 to promote adoption of the method. The event provided information about its applications and the current state of research.

June 30, 2017 — Pulsed cavitation ultrasound can be used to remotely soften human degenerative calcified biosprosthetic valves and significantly improve the valve opening function, according to a novel study published in JACC: Basic to Translational Science. This new noninvasive approach has the potential to improve the outcome of patients with severe bioprosthesis stenosis. 

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now